Évaluation des substances - plan d'action continu communautaire

Évaluation des substances - plan d'action continu communautaire

Évaluation des substances - plan d'action continu communautaire

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 15 avril 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
205-483-3
141-43-5
2014
United Kingdom
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2026
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
229-419-9
6528-34-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
229-355-1
6486-23-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
228-768-4
6358-31-2
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Concluded
Details
219-470-5
2440-22-4
2016
Czech Republic
Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Withdrawn
Details
204-881-4
128-37-0
2016
France
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Follow-up
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
203-872-2
111-46-6
2015
Hungary
Suspected CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-312-7
105-59-9
2013
United Kingdom
Suspected CMR
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-868-0
111-42-2
2012
Germany
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
242-895-2
19224-29-4
2024
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-707-1
98-85-1
2019
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Follow-up
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Withdrawn
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
222-429-4
3468-63-1
2019
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Concluded
Details
273-227-8
68953-84-4
2013
Germany
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
211-463-5
646-06-0
2016
Germany
Suspected Mutagenic
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-308-5
105-55-5
2019
Poland
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
219-514-3
2451-62-9
2015
Poland
CMR
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
203-812-5
110-88-3
2013
Poland
Suspected CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-425-9
95-50-1
2013
Hungary
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
241-867-7
17928-28-8
Norway
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
203-820-9
110-97-4
2013
Czech Republic
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
248-607-1
27689-12-9
2024
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
242-060-2
18172-67-3
2014
Greece
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
225-716-2
5026-74-4
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
215-160-9
1308-38-9
2019
France
Suspected Reprotoxic
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
204-633-5
123-51-3
Poland
Suspected Carcinogenic
Suspected Reprotoxic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
622-542-2
3891-98-3
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Withdrawn
Details
204-077-3
115-27-5
2013
France
CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
204-857-3
127-68-4
Ireland
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Withdrawn
Details
905-459-9
-
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
211-745-8
693-21-0
2016
Italy
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
High RCR
Concluded
Details
432-520-2
232938-43-1
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
941-303-6
-
2026
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
229-912-9
6834-92-0
2015
Latvia
Suspected Reprotoxic
Consumer use
High (aggregated) tonnage
High RCR
Concluded
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Withdrawn
Details
270-877-4
68479-98-1
2016
Denmark
Suspected Mutagenic
Suspected Reprotoxic
Concluded
Details
308-662-5
98171-53-0
2023
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
Ongoing
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Suspended
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Concluded
Details
931-292-6
308062-28-4
Ireland
Suspected Reprotoxic
Other hazard based concern
Withdrawn
Details
204-327-1
119-47-1
2016
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
201-240-0
79-97-0
2021
Germany
Suspected Reprotoxic
Potential endocrine disruptor
Information requested
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Concluded
Details
242-016-2
18127-01-0
Sweden
Suspected Reprotoxic
Withdrawn
Details
221-975-0
3302-10-1
Spain
Suspected Reprotoxic
Exposure of workers
Withdrawn
Details
627-872-0
1514-82-5
2019
Spain
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Follow-up
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
204-278-6
118-79-6
2024
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PMT/vPvM
Other hazard based concern
Exposure of environment
Exposure of workers
Ongoing
Details
220-562-2
2814-77-9
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
219-372-2
2425-85-6
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
202-826-9
100-18-5
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
Not started
Details
202-773-1
99-62-7
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
222-182-2
3380-34-5
2012
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
484-450-7
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Concluded
Details
701-385-4
-
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
ADDITIV 104
412-780-3
1380226-46-9
France
Suspected PBT/vPvB
Concluded
Details
ROBAC AS/100
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Concluded
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
219-006-1
2312-35-8
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Concluded
Details
422-270-2
163702-08-7
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
262-975-0
61788-44-1
2014
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Cumulative exposure
Concluded
Details
273-066-3
68937-41-7
2020
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Information requested
Details
201-344-6
81-33-4
Belgium
Suspected PBT/vPvB
Withdrawn
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Follow-up
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2025
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
209-909-9
597-82-0
2016
Netherlands
Suspected PBT/vPvB
Follow-up
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
IRGANOX L 118
404-800-4
118832-72-7
2014
Germany
Suspected PBT/vPvB
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
272-902-4
68919-76-6
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
404-740-9
115895-09-5
2016
Slovenia
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details

Export search results to: